miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
Zhiyu Chen(Sichuan University), Ashok K. Saluja(Qingdao University), Selwyn M. Vickers(The London College), Vikas Dudeja(University of Alabama at Birmingham Hospital), Tiffany N. MacKenzie(University of Minnesota), Xiaowu Li(Army Medical University), Huaizhi Wang(Chongqing University), Sulagna Banerjee(University of Miami), Veena Sangwan(Dr. Shroff’s Charity Eye Hospital)
Cited by 64
Related Papers
TFOS DEWS II iatrogenic report
|The Ocular Surface|2017|444
Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis – A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease
|The Ocular Surface|2016|219
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
|Journal of Clinical Investigation|2019|211
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
|Frontiers in Immunology|2021|181